MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

Home » Varian receives China NMPA approval for cancer treatment system

Varian receives China NMPA approval for cancer treatment system

By

Varian-Halcyon-system
[Image from Varian Medical Systems]
Varian has received approval from China’s National Medical Product Administration for its Halcyon system to treat cancer.

The Halcyon system is designed to treat cancer patients with radiotherapy to treat lung, prostate, breast, head & neck and other forms of cancer. The system has a human-centered and user-friendly design to improve clinical workflow, accelerate installation timeframes, expedite commissioning, simplify training and automate treatment.

Get the full story on our sister site Medical Design & Outsourcing.

More recent news

About Danielle Kirsh

Danielle Kirsh is an award-winning journalist and senior editor for Medical Design & Outsourcing, MassDevice, and Medical Tubing + Extrusion, and the founder of Women in Medtech and lead editor for Big 100. She received her bachelor's degree in broadcast journalism and mass communication from Norfolk State University and is pursuing her master's in global strategic communications at the University of Florida. You can connect with her on Twitter and LinkedIn, or email her at [email protected].